Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies

2019430 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Journal of Thoracic Oncology

Volume 15, Issue 4, pp. 618-627

Field-Weighted Citation Impact: 24.20